When Your Distributor Owns the Hospital: Governance Questions for Payer-Provider Integration in Group Health

The corporate buyer of group mediclaim has always dealt with a chain of separate commercial interests: a broker who advises, an insurer who prices, a TPA who adjudicates, and hospitals who deliver care and bill for it. Each link had its own incentives, and the friction between them was, in a rough way, the buyer's protection. That structure is changing.

In 2026, the group behind Policybazaar, the country's best-known online insurance distributor, moved into healthcare delivery. Business Today reported on 13 July 2026 that the group had forayed into hospitals under the PB Health name, building an integrated insurance-and-healthcare model, a development Digital Health News also covered during 2026. In August 2026, Medianama reported that PB Fintech had acquired Fitterfly, a digital health platform, to strengthen its preventive-care and chronic-disease management offerings.

The parent has the balance sheet to sustain the build-out. PB Fintech reported a 92% year-on-year rise in consolidated Q1 FY27 profit after tax to Rs 163 crore, with revenue up 40%, per an Equitywizards report on the Q1 results in August 2026. The healthcare arm itself is still in investment mode: Medianama's coverage of the Q1 FY27 earnings call reported that PB Healthcare, the healthcare business incubated by Policybazaar, posted a loss of about Rs 7 crore in the April-June quarter, with management targeting break-even by the end of FY27.

None of this is a scandal, and this post is not a warning against the model. Integrated payer-provider structures exist in many markets and can genuinely lower cost. But when the entity advising on your group mediclaim also owns delivery capacity, network steering stops being a neutral service and becomes a commercial decision with a margin attached. That calls for governance, and governance starts with knowing what to ask.

The integration is a response to a real problem. Indian group health premiums have been hardening on the back of medical inflation that no single insurer controls, because the cost flowing into claims is structural on the provider side. NATHEALTH, the healthcare industry federation, made the point directly on 18 August 2026, saying that healthcare delivery is capital-intensive and that hospital tariffs are only the tip of the iceberg (reported by Asia Insurance Post).

A payer that owns hospitals attacks that problem from inside. It can standardise treatment protocols, buy consumables at scale, and remove the adversarial billing dynamic in which a hospital recovers whatever a package-rate negotiation squeezed out through consumables, room-category pricing and unlisted procedures. Add a chronic-disease platform like Fitterfly and the group can manage the small share of members who drive a disproportionate share of recurring claims, before those claims occur. On paper, every rupee of that efficiency can flow back to the employer as a lower renewal.

The same integration creates the governance question. A hospital business that lost about Rs 7 crore in the June quarter, with management targeting break-even by the end of FY27, has occupancy and revenue targets. The distribution and servicing arms of the same group influence where thousands of insured employees get admitted. The efficiency case and the steering risk are two faces of one structure, and a buyer cannot get the first while ignoring the second.

Network steering is standard practice in group health, and usually works in the employer's favour. Brokers and TPAs push admissions toward hospitals with agreed package rates through cashless eligibility, benefit design and employee communication, so the programme pays negotiated prices instead of rack rates.

The mechanics do not change when the steering entity owns hospitals. The incentives do. Every admission steered into a group-owned facility now carries provider margin for the group, on top of whatever the group earns from distribution and servicing. Steering an employee to the owned hospital may still be the right call: the rate may genuinely be lower, the protocol tighter, the cashless experience smoother. The problem is that the buyer can no longer assume it, because the recommendation and the revenue now point the same way.

The answer is measurement, not suspicion. A corporate buyer should be able to see, each quarter:

• the share of the group's admissions that went to affiliated facilities, and the trend;
• average paid amount per admission for comparable procedures at affiliated versus third-party network hospitals;
• the basis on which affiliated hospitals were included in the steering logic (rate, quality accreditation, location), stated in writing.

When a TPA negotiates a package rate with an independent hospital, two opposing interests discipline the number. When the payer arm and the provider arm sit inside one group, the agreed rate is closer to a transfer price: it allocates margin between two pockets of the same consolidated P&L, and the employer's claims fund pays it either way.

This matters because the rate schedule at affiliated hospitals will be presented as evidence of the model's value. Sometimes it will be genuine value. NATHEALTH's tip-of-the-iceberg point cuts both ways here: the capital intensity it describes applies to group-owned hospitals too, and a business under a public break-even deadline has to recover its build-out cost through the prices and volumes it books.

The test a buyer should apply is benchmarking, and it should be written into the mandate rather than requested ad hoc:

1. Same-procedure, same-city, same-room-category comparison of package rates at affiliated hospitals against at least three third-party network hospitals of comparable accreditation.
2. Comparison of billed-to-paid deduction ratios across the two sets, since a low headline rate with heavy non-package billing is not a low rate.
3. An annual right to have the comparison run or reviewed by an independent party of the employer's choosing.

If the affiliated rates survive that comparison, the integration is delivering what it promises and the employer should use it with confidence. If the group resists the comparison, that resistance is itself the data point.

Adjudication is the second place the conflict can surface, and it can run in either direction. At affiliated hospitals, lighter scrutiny of bills inflates the employer's claims experience and feeds directly into the next renewal quote, which the same group may also be advising on. At competing hospitals, unusually aggressive deductions can make the affiliated network look cheaper than it is, while employees absorb the friction. Employers already know from repudiation patterns across group health insurers that adjudication behaviour varies widely; ownership links add a reason to check whose bills get scrutinised hardest. The established playbook for fraud and leakage control in cashless ecosystems assumes the payer and the provider are adversaries; a buyer should ask what replaces that check when they are not.

The practical fix is symmetry: whatever audit standard applies to third-party hospital bills must demonstrably apply to affiliated hospital bills, and the employer should receive deduction and query statistics split by affiliated versus third-party facilities.

Data is the quieter issue. A group that combines distribution, servicing, hospitals and a chronic-disease platform like Fitterfly can hold, for one employee population, the placement history, the claims record, the clinical encounters and the wellness-programme data. Used well, that produces better chronic-care outcomes. Used without boundaries, health data gathered through a wellness benefit can inform the group's commercial position at the next renewal. The servicing agreement should state what employee health data each group entity may access, for what purpose, on what consent, and whether wellness and chronic-programme data may be used in pricing or placement advice at all.

A buyer evaluating a broker, TPA or health-services partner that belongs to an integrated group should put the following on the table before signing, in writing, with the answers recorded:

1. Ownership map. Which entities in your group own or operate hospitals, clinics, diagnostics, pharmacies or health platforms that could serve our employees? The code of conduct under the IRDAI (Insurance Brokers) Regulations, 2018 requires a broker to disclose conflicts of interest, so a written ownership map is a reasonable ask, not an aggressive one.
2. Steering logic. On what stated criteria will you recommend or configure network hospitals for our programme, and how are affiliated facilities treated in that logic?
3. Remuneration across the group. What does your group earn from our account in total: brokerage, TPA fees, provider margin at affiliated hospitals, and health-programme fees?
4. Adjudication symmetry. Will you report deduction, query and approval statistics split by affiliated versus third-party hospitals?
5. Tariff benchmarking. Will you accept an annual independent benchmark of affiliated-hospital rates as a condition of their inclusion in our steering design?
6. Data boundaries. Which group entities will access our employees' health data, under what consent, and is wellness data ever used in renewal or placement work?
7. Exit. If we move the mandate, what claims, utilisation and clinical data comes with us, in what format, and in what timeframe?

A counterparty that answers these fluently is probably running the model well. A counterparty that treats them as hostile has told you how the conflicts will be managed after signature.

Questions asked at appointment fade unless the answers become obligations. Five clauses convert them:

• Annual conflict disclosure. A standing obligation to disclose, each policy year, all group entities with a commercial interest in the employer's programme, updated within a defined period after any acquisition. The Fitterfly purchase is a live example of why the update trigger matters: the conflict map of an integrated group changes between renewals.
• Quarterly steering report. Defined metrics: affiliated-facility admission share, average paid per comparable admission at affiliated versus third-party hospitals, and deduction statistics split the same way. Metrics defined in the agreement, not left to the report writer.
• Benchmarking right. The independent tariff comparison described above, at least annually, with cooperation (rate schedules, billing data) as a contractual duty.
• Data-use schedule. Entity-by-entity access rights to employee health data, purpose limitation, consent standard, and an express bar on wellness-programme data flowing into pricing or placement advice unless the employer opts in.
• Portability on exit. Claims and utilisation data delivered in a usable electronic format within a defined number of days of mandate transfer, so the conflict of interest never becomes a switching cost. Standardised claim data flows under NHCX make this easier to specify than it used to be.

Running this discipline requires knowing what competing insurers and servicing arrangements actually commit to in their wordings and agreements, because the same headline promise sits on very different terms. Sarvada gives commercial insurance brokers structured, searchable access to insurer policy wordings and the intelligence around them, so group health placements and servicing mandates can be negotiated on the real terms behind each offer. Request Access to ground your next group health governance review in the underlying documents.